The hazards of intermediate endpoints
- 18 October 2007
- Vol. 110 (9) , 1877-1879
- https://doi.org/10.1002/cncr.22995
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The Association Between Measures of Progression and Survival in Castrate-Metastatic Prostate CancerClinical Cancer Research, 2007
- Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxelAnti-Cancer Drugs, 2006
- Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16JNCI Journal of the National Cancer Institute, 2006
- Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled TrialJournal of Clinical Oncology, 2003
- The effect of measuring error on the results of therapeutic trials in advanced cancerCancer, 1976